Author:
Zeisig Reiner,Rückerl Dominik,Fichtner Iduna
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference40 articles.
1. Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade;Gajdos;Clin Breast Cancer,2002
2. Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow;Jordan;J Natl Cancer Inst,1998
3. Steroidal and nonsteroidal oestrogen antagonists in breast cancer: basic and clinical appraisal;Favoni;Trends Pharmacol Sci,1998
4. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats;Greenberger;Clin Cancer Res,2001
5. Clinical potential of new antiestrogens;Gradishar;J Clin Oncol,1997
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献